About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: November 6, 2006
Adolor Corp. Gets Approvable Letter
Today Adolor Corp. announced receipt of an approvable letter from the FDA requesting 12-month safety data that includes an analysis of any cardiovascular related adverse events. The application was for Entereg, indicated for the management of postoperative ileus.
Posted in Clinical Trials
Comments Off on Adolor Corp. Gets Approvable Letter
The Cost of Doing Nothing
The Ryan White CARE Act is the backbone of not only care, but of access to life-saving medications that have made such a dramatic change in the AIDS epidemic by changing mortality rates. The access to these medications is through … Continue reading
Posted in Uncategorized
Comments Off on The Cost of Doing Nothing